4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000028
Chief Legal Officer sold 545 shares at $25.14 ($13,701)
- Chief Legal Officer acquired 1,833 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Burns James William · Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,833 | 32,211 | D | ||
| 2024-02-14 | Sale : show line 2 in the form 10b5-1 | −545 | $25.14 | $13,701 | 31,666 | D |
| Open-market sales · 545 sh · avg $25.14 · $13,701 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-12 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −1,833 | 0 | D |
Loading xslF345X05/wk-form4_1707951087.xml…